This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: The Brigham and Women's Hospital, Inc., The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Ashley Modell: Innovator in Chimeric Molecules
Introduction
Ashley Modell is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of chimeric molecules that have potential therapeutic applications.
Latest Patents
Ashley Modell holds a patent for "Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof." This patent describes chimeric small molecules that serve as modifiers of target substrates. The formula A-L-E-B or A-L-E-L-B is utilized, where A represents a kinase binding moiety, B is a target binding moiety, L and L are linkers, and E is an electrophilic reactive group. These molecules can facilitate substrate modifications, such as post-translational modifications to targets that are not the natural substrate of the kinase. Consequently, they may be used to treat or prevent various diseases or disorders.
Career Highlights
Throughout her career, Ashley has worked with notable organizations, including the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Ashley has collaborated with talented individuals in her field, including Praveen Tiwari and Vika Anokhina. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Ashley Modell is a pioneering inventor whose work on chimeric molecules holds promise for advancing therapeutic strategies. Her contributions to the field of biochemistry are noteworthy and continue to impact the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile